CN112535285A - 减脂排毒酵素粉 - Google Patents
减脂排毒酵素粉 Download PDFInfo
- Publication number
- CN112535285A CN112535285A CN202011439133.0A CN202011439133A CN112535285A CN 112535285 A CN112535285 A CN 112535285A CN 202011439133 A CN202011439133 A CN 202011439133A CN 112535285 A CN112535285 A CN 112535285A
- Authority
- CN
- China
- Prior art keywords
- parts
- fat
- vitamin
- extract
- expelling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000843 powder Substances 0.000 title claims abstract description 50
- 239000003053 toxin Substances 0.000 title claims abstract description 19
- 231100000765 toxin Toxicity 0.000 title claims abstract description 19
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 15
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 15
- 239000002131 composite material Substances 0.000 claims abstract description 43
- 235000015097 nutrients Nutrition 0.000 claims abstract description 33
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 15
- 239000011707 mineral Substances 0.000 claims abstract description 15
- 235000010755 mineral Nutrition 0.000 claims abstract description 15
- 239000000758 substrate Substances 0.000 claims abstract description 13
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 12
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 12
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 claims abstract description 11
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 11
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 claims abstract description 11
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 claims abstract description 11
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 11
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 11
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 11
- 239000001168 astaxanthin Substances 0.000 claims abstract description 11
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 11
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 claims abstract description 11
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 11
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 11
- 239000001963 growth medium Substances 0.000 claims abstract description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 9
- 230000036541 health Effects 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 43
- 108700012359 toxins Proteins 0.000 claims description 16
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 244000269722 Thea sinensis Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 244000045195 Cicer arietinum Species 0.000 claims description 8
- 235000010523 Cicer arietinum Nutrition 0.000 claims description 8
- 241000195493 Cryptophyta Species 0.000 claims description 8
- 241000199919 Phaeophyceae Species 0.000 claims description 8
- 241000206572 Rhodophyta Species 0.000 claims description 8
- 241000223259 Trichoderma Species 0.000 claims description 8
- 229940069765 bean extract Drugs 0.000 claims description 7
- 235000020237 cranberry extract Nutrition 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- 241000624144 Cutaneotrichosporon dermatis Species 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 235000019209 bilberry extract Nutrition 0.000 claims description 6
- 229940102480 bilberry extract Drugs 0.000 claims description 6
- -1 compound vitamin Chemical class 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- 229940072056 alginate Drugs 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 238000000586 desensitisation Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 3
- 229960000355 copper sulfate Drugs 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 229960004839 potassium iodide Drugs 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- 235000008935 nutritious Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 25
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 230000000968 intestinal effect Effects 0.000 abstract description 7
- 210000000936 intestine Anatomy 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 229940088597 hormone Drugs 0.000 abstract description 2
- 239000005556 hormone Substances 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 1
- 230000037237 body shape Effects 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 42
- 230000002829 reductive effect Effects 0.000 description 23
- 239000000126 substance Substances 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 208000008589 Obesity Diseases 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 210000001789 adipocyte Anatomy 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000006041 probiotic Substances 0.000 description 7
- 235000018291 probiotics Nutrition 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229940108924 conjugated linoleic acid Drugs 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 230000013872 defecation Effects 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 6
- 206010033307 Overweight Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 240000001417 Vigna umbellata Species 0.000 description 4
- 235000011453 Vigna umbellata Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000002485 combustion reaction Methods 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000601794 Trichothecium Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000003943 catecholamines Chemical class 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000167550 Centella Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102100033167 Elastin Human genes 0.000 description 2
- 101001043321 Homo sapiens Lysyl oxidase homolog 1 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102100021949 Lysyl oxidase homolog 3 Human genes 0.000 description 2
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 241000223230 Trichosporon Species 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 2
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 235000021582 food-grade substance Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000037219 healthy weight Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 235000006286 nutrient intake Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000632227 Antenoron Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 1
- 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000005272 common selfheal Nutrition 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229960001582 fenfluramine Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- DMDGGSIALPNSEE-UHFFFAOYSA-N hydroflumethiazide Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O DMDGGSIALPNSEE-UHFFFAOYSA-N 0.000 description 1
- 229960003313 hydroflumethiazide Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- 210000000229 preadipocyte Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 210000004116 schwann cell Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229940076742 senna leaves Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000035924 thermogenesis Effects 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种减脂排毒酵素粉,属于生物制剂型保健品技术领域。本发明所述的减脂排毒酵素粉,按重量份数计,每100份排毒酵素粉中包含如下成分:复合营养物酵素粉75~85份,低聚果糖3~7份,岩藻甾醇3~7份,虾青素2~4份,天然茶多酚1~3份,壳寡糖2~4份,复合矿物质1.0~2.0份,复合维生素1.0~2.0份。其中,所述的复合营养物酵素粉通过真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)经过特定底物培养基发酵后获得。本发明具有清肠排毒、疏通三淤、养颜抗衰、醒酒利水、清肠通便、改善内环境、降脂降压、重塑肠道生态菌群、减脂美体等功效,能够调整机体恢复正常的激素水平,唤醒机体自身的修复能力,改善机体内环境,加速脂肪动员,由内而外重塑身形,让人体细胞重新焕发活力。
Description
技术领域
本发明涉及含有生物制剂型的减脂排毒美容保健品,具体是一种减脂排毒酵素粉。
背景技术
湿是身体万恶之源,湿气重时,人体会出现头重如裹、肢体困重麻木、肌肉酸痛、倦怠乏力、纳呆食少、完谷不化、口黏乏味、口中黏腻、便溏腹泻、妇女白带过多、阴部瘙痒、身体湿胖等症状,严重影响我们的日常生活。
我国排毒瘦身产品已历经了三个阶段,第一阶段设计思想主要基于因营养摄取过盛与吸收亢进而肥胖的观点,采取清泄型减肥方法,主要适用于人体能量摄入过多的肥胖者;第二阶段设计思想主要基于因营养结构不良与机体代谢功能低下而肥胖的观点,主张在补充均衡膳食营养的同时,采取部分替食型的减肥方法;第三阶段设计思想主要基于肥胖是由于体内菌群结构失衡,通过外界摄入的手段,人工干预平衡体内菌群结构,从而达到减脂的效果。
现代社会,快节奏不规律的生活方式和工作,导致人体的生物钟和生活习惯,不再与生命诞生之初相一致,长期的高压高负荷状态下工作和生活习惯导致人体代谢机能失调、体外营养摄取失衡、精神情志心态失和;由于工作生活习惯致使决大多数人群的饮食方式和饮食结构也发生了重大改变,这些都是造成人体内毒素、湿气、脂肪等代谢废物不能排出体外的重要原因。通过控制饮食、调整饮食结构、改善体内菌群等单一方法,已经不能解决上述问题。
市面上现有的排毒、减肥产品中,绝大多数都含有番泻叶、金钱草、夏枯草等寒凉成分,通过促进排泄导致体重的下降的成分;或含有甲状腺激素、去氢表雄素、生长激素、大黄素等减脂激素类药物;或含有氢氟噻嗪、芬氟拉明、西布曲明、氟西汀等减肥违禁药物;或含有L-左旋肉碱、奥利司他等减肥噱头药物;这些只能破坏人体肠粘膜上的益生菌种的平衡,加重水肿,导致恶性循环,不宜长期使用。
本发明在中医除湿的理论基础上,创造性的通过微生物发酵的方式,采用纯天然的制作工艺,得到了一种既能重塑人体益生菌群,又能快速、持续的排毒、减脂、瘦身、美容产品,通过改善人体内环境,协调人体各个器官的代谢,调动体液循环和淋巴循环,减少碳水化合物的吸收,加快脂肪动员,排出体内多余的湿气和水肿,科学合理的协调人体肌肉和脂肪的组成及分布,让皮肤重新恢复年轻态。
发明内容
本发明要解决的技术问题是提供一种既含有高科技益生菌菌剂,同时又具有减脂、排毒、美容功能的酵素粉。
本发明解决其技术问题采用的技术方案是:
本发明首先提供一种真皮毛孢子菌(Trichosporon dermatis),其保藏编号为:CGMCC No.14875。
本发明还提供了所述的真皮毛孢子菌(Trichosporon dermatis)在制备复合营养酵素粉中的应用。
本发明提供一种减脂排毒酵素粉,按重量份数计,每100份减脂排毒酵素粉,包含如下成分:复合营养物酵素粉75~85份,低聚果糖3~7份,岩藻甾醇3~7份,虾青素2~4份,天然茶多酚1~3份,壳寡糖2~4份,复合矿物质1.0~2.0份,复合维生素1.0~2.0份;
本发明通过将减脂排毒酵素粉中的原料充分混合均匀,得到所述的减脂排毒酵素粉。
其中,所述的复合营养物酵素粉通过如下方法制备:
真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)经过含有复合营养物质提取物的培养基发酵后,经过真空冷冻干燥、减毒、脱敏、提取、纯化、精炼、脱色工艺,经过超声粉碎后,得到白色的达到纳米级粒径的复合营养物酵素粉。
所述的含有复合营养物质提取物的培养基组成为:葡萄糖15.0g/L,蛋白胨10.0g/L,酵母浸粉5.0g/L,NaCl 1.0g/L,复合营养物质提取物50.0g/L,蒸馏水1000ml。
发酵条件为:接菌量10-20g/L,35-40℃,摇床培养48~72小时,至其中活性益生菌浓度为5×1011CFU时止。
所述的复合营养物质提取物由红花菜豆提取物、鹰嘴豆提取物、越桔果提取物、蔓越莓提取物、积雪草提取物、红藻提取物、蓝藻提取物、褐藻提取物组成。
所述的红花菜豆提取物、鹰嘴豆提取物、越桔果提取物、蔓越莓提取物、积雪草提取物、红藻提取物、蓝藻提取物、褐藻提取物均可以通过商购获得。
所述的低聚果糖、岩藻甾醇、虾青素、天然茶多酚、壳寡糖,均为食品级物质,纯度99%以上,且经过超声粉碎后,达到纳米级粒径,便于人体吸收。
所述的复合矿物质包含CD-钙、SAC-藻酸盐、碘化钾、硫酸铜、葡萄糖酸锌、亚硒酸钠、四维亚铁、碳酸镁、硫酸锰、富铬酵母中的两种或多种,均为食品级物质,纯度99.9%以上,且经过超声粉碎后,达到纳米级粒径,便于人体吸收。
所述的复合维生素包含维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、生物素、叶酸、泛酸中的两种或多种,均为食品级物质,纯度99.9%以上,且经过超声粉碎后,达到纳米级粒径,便于人体吸收。
上述功能组分所起到的作用如下:
1.复合营养物酵素粉:由浓度为5×1011CFU的活性益生菌通过发酵特定底物培养基后,经过真空冷冻干燥、减毒、脱敏、提取、纯化、精炼、脱色工艺,经过超声粉碎,达到纳米级粒径而得到的白色成品。其特定底物培养基包含红花菜豆提取物、鹰嘴豆提取物、越桔果提取物、蔓越莓提取物、积雪草提取物、红藻提取物、蓝藻提取物、褐藻提取物等营养物质。含有如下成分:
(1)不饱和脂肪酸:包括杏仁油/酸(C18:1,顺-9)、反式油酸(C18:1,反-9)、蓖麻油酸(C18:1,顺-9)、芥酸(C22:1,顺-13)等单不饱和脂肪酸以及二十碳五烯酸(DHA)、二十二碳六烯酸(EPA)、亚油酸、共轭亚油酸、α-亚麻酸、花生四烯酸、花籽油等多不饱和脂肪酸,其中的共轭亚油酸含量更是高达43%,是一种纯天然的降脂排毒美容产品,能够显著提高肉碱棕榈油酰转移酶(CPT)的活性,提高脂肪酸的转运速度,增加脂肪代谢率;是天然的抗癌活性物质,具有十分优良的营养作用以及良好的抗氧化稳定性,能够降低胆固醇,保持细胞膜的相对流动性,降低血液粘度,提高细胞活性,降血脂、抗炎抗癌、调节代谢、增肌减脂、改善血液循环、增强机体免疫力、减缓免疫系统副反应等功能。
(2)红花菜豆提取物、鹰嘴豆提取物、红藻提取物:可显著增加身体中乙酰胆碱的分泌,可以促进交感神经兴奋,释放抗利尿激素和β-内啡肽,在减脂的同时,可有效避免体内水分的过度流失,提高身体的免疫能力,延缓阿尔兹海默症的发病。
(3)越桔果提取物:富含天然视紫质和类黄酮,能够改善微循环,调节微血管血液流量;抑制自由基对毛细血管的损害;加速视紫红质的再生速率,改善视力,减轻目眩,提高暗适应。
(4)蔓越莓提取物:富含丰富的原花青素,具有强抗氧化的作用,清除细胞膜中水溶性和脂溶性的自由基,有效消除超氧阴离子自由基和羟基自由基,消除水肿,恢复胶原蛋白活力,在促进维生素C的吸收和利用的同时,和维生素C协同作用加速胆固醇的分解和排出。
(5)积雪草提取物:可促进人体转化生长因子-β(TGF-β)mRNA和基质重金属蛋白酶的表达,促进成纤维细胞、成骨细胞和雪旺氏细胞的生长,激活赖氨酸氧化酶(LOXL)的合成,在铜离子的作用下,LOXL能够促进胶原纤维发育成熟,保持内环境稳态,促使微纤维和弹性蛋白原聚合,使肌肤结构得到重塑,并持久保持肌肤张力,恢复肌肤弹性,从而达到紧致塑形的作用。
(6)蓝藻提取物:清肠毒、减脂、净化血液、改善心血管疾病、美容养颜、调节酸碱平衡、改善体质、解酒、延缓衰老、促进细胞新陈代谢、增强大脑活力、增加抵抗力。
(7)褐藻提取物:有效抑制淀粉酶和脂肪酶的活性,阻止肠胃对淀粉和脂肪类物质的分解和吸收,降低因过量的碳水化合物摄入而引起的肥胖,同时有促进产热的作用,可参与调节T3和T4促甲状腺激素的天然合成,促进正常代谢活动,产生热量,燃烧脂肪。
(8)发酵后得到的复合营养物酵素粉,具有维持机体正常功能、消化食物、修复组织等生命活动等功能。可以促进蛋白质、糖类、脂肪三大营养素的分解,清宿便、排肠毒、分解腰腹部脂肪效果显著。可以去除赘肉,缩小肥大细胞,促进新陈代谢,及时把多余脂肪排出体外;同时将脂肪分解为脂肪酸,促进蛋白质消化,有利于人体将堆积在下半身的脂肪快速燃烧,让腹部多余的脂肪慢慢消失,身材变得苗条起来。同时还可以帮助溶解毛孔中堆积的皮脂及老化角质,使肌肤嫩滑细腻,显得更明亮、更清新。
2.低聚果糖:可以提供大量的益生元,重建肠道生态菌群,调动人体自身的代谢机制,促进体内毒素排出,使肌肤重现光泽。
3.岩藻甾醇:直接作用于真皮组织,起到脂解和固化的作用,保持人体内环境稳定,控制糖原和矿物质的代谢,调节应激反应,防治癌症,明显降低血液中的胆固醇。
4.虾青素:是一种萜烯类不饱和化合物,具有极强的抗肿瘤、抗氧化性能,可以增强免疫力,清除体内自由基,改善微循环,减小冠状动脉和大动脉的血管壁厚度,抑制动脉硬化。具有中枢神经系统的保护作用、预防心血管疾病、增强免疫力、缓解运动疲劳、抗炎抗感染、抑制肿瘤、抑制糖尿病肾病等作用;同时能够有效清除细胞内的氧自由基,增强细胞的再生能力,维持机体平衡和减少衰老细胞的堆积,由内而外保护细胞和DNA的健康,抑制原位活性氧(ROS)和基质金属蛋白酶(NMP)的生成及累积,减弱ROS和NMP对真皮层胶原蛋白、弹力蛋白的破坏,恢复皮肤的正常紧致。
5.天然茶多酚:能够抑制脂肪吸收,促进脂肪燃烧,清肠排毒,改善肠道菌落环境。
6.壳寡糖:通过促进胰岛β-细胞的增殖来修复受损胰岛组织并促进胰岛素分泌进而降低血糖水平;同时是自然界中唯一存在的带正电荷的低聚糖,通过带正电荷的碱性氨基结合脂肪,使油脂不易被机体消化吸收进而被排出体外,可降低对胆固醇的吸收量,有效下调某些与肥胖相关的基因表达量,抑制脂肪细胞的分化。
7.复合矿物质:为人体提供必要的矿物质元素,避免每日矿物质摄入不足导致的疾病发生,其中:(1)CD-钙:能够通过降低微血管壁通透性,增加其抵抗力,增加血浆酶原活性物质,活化淋巴循环系统,促进淋巴循环,促进体内水分和毒素排出;(2)SAC-藻酸盐:可促进人体肌肤持久保湿,固定皮肤中必要的自由水,刺激成纤维细胞的生长,分解脂肪,促进肌肤紧致;(3)碘化钾:能有助于热量的消耗和脂肪燃烧。
8.复合维生素:为人体提供必要的维生素,避免每日维生素摄入不足导致的疾病发生,其中:(1)维生素B、维生素C:可以刺激饱腹中枢的兴奋,促进肠胃蠕动,分解体内多余的碳水化合物,同时阻断外界碳水化合物的摄入,排除体内毒素和垃圾。(2)维生素D、维生素E:可以加快血液中游离脂肪酸的分解,使血液中游离脂肪酸的浓度降低,降低摄食中枢的兴奋度,使机体不产生饥饿感,从而减少食物的摄入;促进睾酮素的分泌,进而刺激β肾上腺素能受体分泌肾上腺素、去甲肾上腺素、促肾上腺皮质激素等儿茶酚胺类物质,儿茶酚胺类物质通过β受体增加氧耗量而产热,促进机体内脂肪物质的分解;同时,儿茶酚胺类物质增加脂肪细胞中激素敏感性脂肪酶和脂肪甘油三酯脂酶的分泌,调动脂肪动员,使储存在脂肪细胞中的脂肪,被逐步水解为游离脂肪酸及甘油并释放入血液,被其他组织氧化利用,从而达到减脂的作用。
上述技术方案基于如下原则而设计:
1.设计原则和方向:
(1)具有合理的营养素比例;(2)具有显著的排毒、排湿、瘦身效果;(3)具有较小的分子量和分子粒径,便于快速吸收;(4)具有快速见效的特性和持久稳固的特性; (5)不会造成内分泌失调和内循环紊乱;(6)不含有任何违禁药物成分,属于纯天然的发酵产物;(7)具有气味清新,口感宜人的特性;(8)具有市场经济性。
2.选取特定菌种对特定底物发酵的机制机理:
(1)菌种HT-925真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)发酵特定底物可以得到富含大量维生素D、维生素E、维生素K的发酵产物,这些维生素,可以促进体内儿茶素的合成,具有以下功能:①降低消耗酶活力,减少食物摄入和能量的吸收;②增加脂肪分解、氧化和燃烧;③调节脂蛋白的表达;④减少前脂肪细胞和脂肪细胞的数量,使体重下降,从而达到促进脂肪代谢,增强减脂的效果;
(2)菌种HT-925真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)发酵特定底物得到的产物中,不饱和脂肪酸中的共轭亚油酸(CLA)含量高达43%。CLA能够使肉碱棕榈酰转移酶的活性增加,并抑制脂蛋白脂酶的活性。即促进脂肪酸β-氧化酶合成,加速脂肪在体内燃烧,从而使体脂降低;同时抑制甘油三酯分解成游离脂肪酸,阻断体脂增加,减少脂肪酸进入脂肪细胞。具有以下功能:①增加脂肪代谢的速率,使摄取的脂肪更多地进入肌肉细胞被氧化,变成能量被利用;②提高脂肪细胞中脂类降解的速率,降低已经储存在体内的脂肪,使脂肪细胞变小;③减少脂肪细胞的数量。
(3)菌种HT-925真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)发酵特定底物得到的产物可逐步改善人体的饮食习惯,促进血液和淋巴循环,促进新陈代谢,促进肾部血液循环,加强肾部淋巴系统排毒功能,使脂肪团萎缩变小,从而达到排毒排水消肿的作用。
(4)菌种HT-925真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)发酵特定底物得到的产物能够有效促进脂肪燃烧,清肠排毒,改善肠道菌落环境,且在燃脂瘦身方面效果显著,同时能改善肠道菌落环境、保持人体均衡营养、增强人体免疫力。
采用上述技术方案的本发明,与现有技术相比,有益效果是:
1.本发明选择由实验室长期驯化的菌种HT-925真皮毛孢子菌发酵特定底物的培养基,从而获取具有高浓度共轭亚油酸并且兼具各类提取物精华的活菌酵素,有效解决了红花菜豆、鹰嘴豆、越桔果、蔓越莓、积雪草、红藻、蓝藻、褐藻等物质不能被人体有效吸收的问题;
2.本发明的酵素粉,拥有超过千亿浓度的活菌成分,能够有效提供益生菌生长所需益生元,迅速改善已经被破坏的肠道菌群分布,切实有效的改善内环境;
3.本发明功能全面、性质温和、配伍合理、使用简便、无过敏现象、不会对人体产生不良反应;
4.本发明能够从根本上解决现代生活节奏给人们带来的湿毒长期积累导致的内分泌失调、虚胖臃肿、腹胀便秘、高血压、高血脂、高血糖等亚健康问题;
5.本发明具有醒酒利水、清肠通便、改善内环境、降脂降压、重塑肠道生态菌群、减脂美体等功效;
6.本发明具有清肠排毒、清除宿便的功能,有助于恢复身体菌群平衡,排肠毒血毒;
7.本发明具有疏通气淤、湿淤、血瘀的功能,可清除对面部色斑,疏通乳腺堵塞,缓解痛经等问题;
8.本发明具有养颜抗衰的功能,可以使皮肤变得更加细腻,皱纹变淡,提亮肤色;
9.本发明通过调整机体恢复正常的激素水平,从而唤醒机体自身的修复能力,改善机体内环境,加速脂肪动员,由内而外重塑身形,让人体细胞重新焕发活力。
本发明所述真皮毛孢子菌(Trichosporon dermatis),保藏于中国微生物菌种保藏管理委员会普通微生物中心,保藏地址:北京市朝阳区北辰西路1号院3号中国科学院微生物研究所,保藏日期:2017年11月13日,保藏编号为:CGMCC No.14875。
附图说明
图1为服用本发明实施例1-6的体重变化图;
图2为服用本发明实施例1-6的BMI指数变化图。
具体实施方式
以下结合实施例详细本发明。
如下实施例中:
所述复合矿物质由CD-钙、SAC-藻酸盐、碘化钾、硫酸铜、葡萄糖酸锌、亚硒酸钠、四维亚铁、碳酸镁、硫酸锰、富铬酵母组成。
所述的复合维生素由维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、生物素、叶酸、泛酸组成。
复合营养物酵素粉的制备:
真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)经过含有复合营养物质提取物的底物培养基发酵,经过真空冷冻干燥、减毒、脱敏、提取、纯化、精炼、脱色工艺,经过超声粉碎后,得到白色的达到纳米级粒径的复合营养物酵素粉。
所述的含有复合营养物质提取物的底物培养基组成为:葡萄糖15.0g/L,蛋白胨10.0 g/L,酵母浸粉5.0g/L,NaCl 1.0g/L,复合营养物质提取物50.0g/L,蒸馏水1000ml。
发酵条件为:接菌量10-20g/L,35-40℃,摇床培养48~72小时,至其中活性益生菌浓度为5×1011CFU时止。
所述的复合营养物质提取物由红花菜豆提取物、鹰嘴豆提取物、越桔果提取物、蔓越莓提取物、积雪草提取物、红藻提取物、蓝藻提取物、褐藻提取物组成。
所述的红花菜豆提取物、鹰嘴豆提取物、越桔果提取物、蔓越莓提取物、积雪草提取物、红藻提取物、蓝藻提取物、褐藻提取物通过商购获得。
实施例1:
一种减脂排毒酵素粉,按重量份数计,由复合营养物酵素粉85份,低聚果糖4份,岩藻甾醇3份,虾青素3份,天然茶多酚1份,壳寡糖2份,复合矿物质1.0份,复合维生素 1.0份组成,所述原料充分混合均匀,即为成品。
实施例2:
一种减脂排毒酵素粉,按重量份数计,由复合营养物酵素粉83份,低聚果糖3份,岩藻甾醇3份,虾青素2份,天然茶多酚3份,壳寡糖3份,复合矿物质1.0份,复合维生素 2.0份组成,所述原料充分混合均匀,即为成品。
实施例3:
一种减脂排毒酵素粉,按重量份数计,由复合营养物酵素粉80份,低聚果糖5份,岩藻甾醇4份,虾青素3份,天然茶多酚2份,壳寡糖2份,复合矿物质2.0份,复合维生素 2.0份组成,所述原料充分混合均匀,即为成品。
实施例4:
一种减脂排毒酵素粉,按重量份数计,由复合营养物酵素粉80份,低聚果糖4份,岩藻甾醇4份,虾青素4份,天然茶多酚3份,壳寡糖2份,复合矿物质1.5份,复合维生素 1.5份组成,所述原料充分混合均匀,即为成品。
实施例5:
一种减脂排毒酵素粉,按重量份数计,由复合营养物酵素粉78份,低聚果糖7份,岩藻甾醇5份,虾青素2份,天然茶多酚2份,壳寡糖3份,复合矿物质1.5份,复合维生素 1.5份组成,所述原料充分混合均匀,即为成品。
实施例6:
一种减脂排毒酵素粉,按重量份数计,由复合营养物酵素粉75份,低聚果糖7份,岩藻甾醇7份,虾青素2份,天然茶多酚2份,壳寡糖4份,复合矿物质1.5份,复合维生素 1.5份组成,所述原料充分混合均匀,即为成品。
应用案例:
案例1,张某某,女,32岁,已婚,身高156cm,空腹体重65kg,腰围69cm,腿围 53cm,BMI指数为26.7,属于超重。使用本发明实施例6后,2小时内体重减轻1.2kg,5 小时内体重减轻2.4kg,次日清晨便秘症状改善,排便畅通且臭,空腹体重61.5kg;坚持服用一周后,腰围67cm;坚持服用一个月后,体重稳定在57.5kg,腰围64cm,腿围 51cm,BMI指数为23.6,达到健康体重标准。
案例2,李某某,女,36岁,已婚,身高162cm,空腹体重67kg,腰围67cm,腿围 54cm,BMI指数为25.5,属于超重。使用本发明实施例2后,2小时内体重减轻1.0kg,5 小时内体重减轻2.3kg,当日睡前即有排便感,排便畅通且臭,次日空腹体重63.5kg;坚持服用一周后,腰围65cm;坚持服用一个月后,体重稳定在58.7kg,腰围64cm,腿围50cm,瘦腿效果明显,BMI指数为22.4,达到健康体重标准。
案例3,季某某,女,42岁,已婚,身高160cm,空腹体重72kg,腰围80cm,腿围 55cm,BMI指数为28.1,属于肥胖,高压145mmHg,低压85mmHg,属于轻度高血压。使用本发明实施例3后,2小时内体重减轻1.5kg,5小时内体重减轻3.0kg,次日清晨排便畅通且臭,空腹体重68kg;坚持服用一周后,腰围75cm;坚持服用一个月后,体重稳定在 62.5kg,腰围71cm,腿围51cm,BMI指数为24.4,比健康体重标准略高,高压130mmHg,低压85mmHg,高血压症状得到改善。
案例4,莫某某,女,27岁,未婚,经常熬夜加班,身高155cm,空腹体重60kg,腰围65cm,腿围53cm,BMI指数为24.9,属于轻度超重。使用本发明实施例5后,2小时内体重减轻0.8kg,5小时内体重减轻1.2kg,次日清晨便秘症状改善,空腹体重58kg;坚持服用一周后,腰围63cm;坚持服用一个月后,体重稳定在54kg,腰围62cm,腿围50cm,瘦腰美腿效果明显,BMI指数为22.4,达到健康体重标准。
案例5,邹某某,男,37岁,已婚,经常熬夜喝酒,身高170cm,空腹体重87kg,腰围110cm,BMI指数为30.1,属于肥胖。使用本发明实施例1后,2小时内体重减轻1.5kg,5 小时内体重减轻2.5kg,次日清晨排便增多,空腹体重83.5kg;坚持服用一周后,腰围 106cm;坚持服用一个月后,体重稳定在80kg,腰围102cm,瘦腰效果明显,BMI指数为 27.6,从肥胖降低到超重标准。
案例6,魏某某,男,47岁,已婚,经常出差应酬、熬夜喝酒,生活极不规律,身高166cm,空腹体重78kg,腰围100cm,BMI指数为28.3,属于肥胖。使用本发明实施例4后, 2小时内体重减轻1.0kg,5小时内体重减轻2.0kg,次日清晨排便增多,空腹体重 74.5kg;坚持服用一周后,腰围98cm;坚持服用一个月后,体重稳定在70kg,腰围94cm,瘦腰效果明显,BMI指数为25.4,从肥胖降低到超重标准。
需要说明的是,只要不构成冲突,本发明上述各个实施例以及各实施例中的各个特征可以相互结合,所形成的技术方案均在本发明的保护范围之内。
Claims (10)
1.真皮毛孢子菌(Trichosporon dermatis),其保藏编号为:CGMCC No.14875。
2.权利要求1所述的真皮毛孢子菌(Trichosporon dermatis)在制备复合营养酵素粉中的应用。
3.权利要求1所述的真皮毛孢子菌(Trichosporon dermatis)在制备减脂排毒酵素粉中的应用。
4.减脂排毒酵素粉,其特征在于,按重量份数计,每100份减脂排毒酵素粉,包含如下成分:复合营养物酵素粉75~85份,低聚果糖3~7份,岩藻甾醇3~7份,虾青素2~4份,天然茶多酚1~3份,壳寡糖2~4份,复合矿物质1.0~2.0份,复合维生素1.0~2.0份。
5.如权利要求4所述的减脂排毒酵素粉,其特征在于,所述的复合营养物酵素粉通过如下方法制备:
真皮毛孢子菌(Trichosporon dermatis,CGMCC No.14875)经过含有复合营养物质提取物的底物培养基发酵后,经过真空冷冻干燥、减毒、脱敏、提取、纯化、精炼、脱色工艺,经过超声粉碎后,得到白色的达到纳米级粒径的复合营养物酵素粉。
6.如权利要求5所述的减脂排毒酵素粉,其特征在于,所述的底物培养基组成为:葡萄糖15.0g/L,蛋白胨10.0g/L,酵母浸粉5.0g/L,NaCl 1.0g/L,复合营养物质提取物50.0g/L,蒸馏水1000ml。
7.如权利要求6所述的减脂排毒酵素粉,其特征在于,发酵条件为:接菌量10-20g/L,35-40℃,摇床培养48~72小时。
8.如权利要求6所述的减脂排毒酵素粉,其特征在于,所述的复合营养物质提取物由红花菜豆提取物、鹰嘴豆提取物、越桔果提取物、蔓越莓提取物、积雪草提取物、红藻提取物、蓝藻提取物、褐藻提取物组成。
9.如权利要求6所述的减脂排毒酵素粉,其特征在于,所述的复合矿物质为CD-钙、SAC-藻酸盐、碘化钾、硫酸铜、葡萄糖酸锌、亚硒酸钠、四维亚铁、碳酸镁、硫酸锰、富铬酵母中的两种或多种组成;所述的复合维生素为维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、生物素、叶酸、泛酸中的两种或多种组成。
10.权利要求4-9任何一项所述的减脂排毒酵素粉在制备减脂排毒食品或保健品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011439133.0A CN112535285A (zh) | 2020-12-11 | 2020-12-11 | 减脂排毒酵素粉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011439133.0A CN112535285A (zh) | 2020-12-11 | 2020-12-11 | 减脂排毒酵素粉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112535285A true CN112535285A (zh) | 2021-03-23 |
Family
ID=75019920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011439133.0A Withdrawn CN112535285A (zh) | 2020-12-11 | 2020-12-11 | 减脂排毒酵素粉 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112535285A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115777933A (zh) * | 2022-12-13 | 2023-03-14 | 青岛琛蓝生物营养技术有限公司 | 一种调节代谢、减脂控糖的组合物及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107125664A (zh) * | 2017-06-08 | 2017-09-05 | 哈尔滨瑞康源生物科技有限公司 | 治疗便秘减少体内脂肪的营养食品及其制备方法 |
CN110974735A (zh) * | 2019-09-23 | 2020-04-10 | 田宇 | 植物精华酵母软膜粉 |
-
2020
- 2020-12-11 CN CN202011439133.0A patent/CN112535285A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107125664A (zh) * | 2017-06-08 | 2017-09-05 | 哈尔滨瑞康源生物科技有限公司 | 治疗便秘减少体内脂肪的营养食品及其制备方法 |
CN110974735A (zh) * | 2019-09-23 | 2020-04-10 | 田宇 | 植物精华酵母软膜粉 |
Non-Patent Citations (1)
Title |
---|
张荣平: "《云南省生物医药发展研究》", 30 April 2020, 云南大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115777933A (zh) * | 2022-12-13 | 2023-03-14 | 青岛琛蓝生物营养技术有限公司 | 一种调节代谢、减脂控糖的组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101646156B1 (ko) | 숙변 제거 효능이 있는 장 기능 개선 발효식품 및 그 제조방법 | |
CN102451363A (zh) | 中草药减肥茶 | |
CN105533001A (zh) | 一种具有排毒润肠通便及减肥功效的发酵茶 | |
CN112772813A (zh) | 一种提高免疫力缓解疲劳的复合肽固体饮料及其制备方法 | |
CN105394428A (zh) | 可提高鸡蛋质量的中药鸡饲料 | |
CN112999261A (zh) | 一种舒缓动脉硬化的纳豆发酵组合物及其制备方法和应用 | |
CN101715851B (zh) | 一种减肥茶及其生产制作工艺 | |
CN106387582A (zh) | 一种谷物类发酵制备酵素的方法 | |
KR102403309B1 (ko) | 건강 개선을 위한 천연성의 조성물과 이를 포함한 기능성 화장제 | |
CN111000252A (zh) | 一种减脂且营养均衡的代餐食品及其制备方法 | |
CN104687193A (zh) | 一种低聚果糖饮料及其制备方法 | |
CN112535285A (zh) | 减脂排毒酵素粉 | |
CN105687558A (zh) | 一种儿童湿疹用植物提取物组合物及其在化妆品中的应用 | |
CN111184214A (zh) | 酵素胶原蛋白杂粮果蔬即食代餐粥及其制作方法 | |
CN106387891B (zh) | 一种雪莲培养物人参营养粉及其制备方法 | |
CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
KR102197395B1 (ko) | 황칠나무 발효 추출물과 매생이 발효 추출물이 혼합 조성된 숙취 해소 복합 발효 추출물의 제조방법 | |
CN103564047B (zh) | 一种美白祛痘芦荟发酵乳及其制备方法 | |
CN111939115A (zh) | 一种天然植物精华修护面膜及其制备方法 | |
KR101458823B1 (ko) | 천연 발효물을 이용한 집중력향상 또는 성장발육촉진을 위한 건강기능식품 및 이의 제조방법 | |
KR20120066380A (ko) | 사슴뼈의 분말을 이용한 한방 건강보조식품 | |
KR102195717B1 (ko) | 복숭아열매추출물을 포함하는 화장료 조성물의 제조방법 및 복숭아열매추출물을 포함하는 화장료 조성물 | |
KR20190049162A (ko) | 천연약재를 이용한 발효조성물, 그의 제조방법 및 이를 포함하는 식품 | |
CN114868824A (zh) | 一种双肽瘦身咖啡 | |
KR20140065924A (ko) | 양파껍질 분말을 주제로 하는 건강 보조식품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210323 |
|
WW01 | Invention patent application withdrawn after publication |